Obstetric and neonatal outcomes among pregnant patients with cystic fibrosis
European Journal of Obstetrics & Gynecology and Reproductive Biology · 2024
DOI: 10.1016/j.ejogrb.2024.06.045 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Obstetrics & Gynecology and Reproductive Biology, 2024. Verfasst von Sam Amar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. Electronic address: sam.amar@mail.mcgill.ca. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pregnancy Outcome, Pregnancy Complications. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: The pregnancy, delivery, and neonatal outcomes of pregnancies complicated by cystic fibrosis (CF) have yet to be evaluated in a prolonged, population-based study. We sought to evaluate the obstetric and neonatal outcomes in pregnant patients with CF using a national population database. STUDY DESIGN: Retrospective population-based cohort study utilizing the Healthcare Cost and Utilization Project, Nationwide Inpatient Sample (HCUP-NIS). All women who delivered or had a maternal death in the US (2004-2014) were included in the study. Pregnancy, delivery, and neonatal outcomes were compared between women with an ICD-9 diagnosis of cystic fibrosis to those without. RESULTS: Overall, 9 096 159 women met the inclusion criteria. Of these, 629 women (6.9/100000) had CF. Women with CF were more likely to be younger and have pregestational diabetes mellitus compared to those without. CF in pregnancy was associated with an increased risk of developing gestational diabetes mellitus [aOR 3.20 (95 %CI 2.48-4.15), p = 0.0001], placenta previa [aOR 2.74 (95 %CI 1.30-5.79), p = 0.008], preterm delivery [aOR 2.17 (95 %CI 1.71-2.77), p = 0.0001], operative vaginal delivery [aOR 1.59 (95 %CI 1.17-2.16), p = 0.003], and death [aOR 86.41 (95 %CI 30.91-241.58), p = 0.0001], and a decreased likelihood of having a spontaneous vaginal delivery [aOR 0.80 (95 %CI 0.66-0.97), p = 0.02]. Patients with CF were more likely to experience deep venous thrombosis [aOR 7.64 (95 %CI 1.90-30.72), p = 0.004] and disseminated intravascular coagulation [aOR 3.68 (95 %CI 1.37-9.87), p = 0.01] compared to those without. The risk of delivering a fetus with congenital anomalies was similar between groups. CONCLUSION: Pregnant patients with CF have an increased risk of developing adverse maternal and delivery outcomes. As such, these patients should receive vigilant surveillance during pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada. Electronic address: sam.amar@mail.mcgill.ca.
- Department of Obstetrics and Gynecology, King Abdulaziz University, Rabigh Branch, Rabigh, Saudi Arabia.
- Department of Obstetrics and Gynecology, University of Tabuk, Tabuk, Saudi Arabia.
- Department of Obstetrics and Gynecology, McGill University, 845 Rue Sherbrooke O, Montreal, QC 3HA 0G4, Canada.
Zitieren
APA
Amar, S., Badeghiesh, A., Baghlaf, H., & Dahan, M. H. (2024). Obstetric and neonatal outcomes among pregnant patients with cystic fibrosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. https://doi.org/10.1016/j.ejogrb.2024.06.045
Vancouver
Amar S, Badeghiesh A, Baghlaf H, Dahan MH. Obstetric and neonatal outcomes among pregnant patients with cystic fibrosis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2024. doi:10.1016/j.ejogrb.2024.06.045
BibTeX
@article{Amar2024,
author = {Amar, Sam and Badeghiesh, Ahmad and Baghlaf, Haitham and Dahan, Michael H},
title = {Obstetric and neonatal outcomes among pregnant patients with cystic fibrosis},
journal = {European Journal of Obstetrics & Gynecology and Reproductive Biology},
year = {2024},
doi = {10.1016/j.ejogrb.2024.06.045}
}
EUVIMED